[주식 등의 대량보유 상황 보고] — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

Disclosure Information

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

Disclosure Information

Sep 2, 2022

[주식 등의 대량보유 상황 보고]

- 보고사유: 우리사주 예탁, 주식담보대출

[공시 원문 바로가기]